GM1 ganglioside effectively treats patients with Parkinson's disease News-Medical.net Treating Parkinson's disease patients with the experimental drug GM1 ganglioside improved symptoms and slowed their progression during a two and a half-year trial, Thomas Jefferson University researchers report in a new study published online November ... and more ยป...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to GM1 ganglioside effectively treats patients with Parkinson's disease - News-Medical.net
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account